Product Information
LAMIVUDINE 300 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.3821 per EA under NDC 31722075430. Its NADAC has been published 486 times since Jun 4, 2014.
Strength
300 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722075430
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
10/23/2024
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA203277On Market Since
1/6/2014
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE 300 MG TABLET has been published 486 times since Jun 4, 2014, and over the history we have for it it has declined 82.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3821 per EA |
|---|---|
| All-time high | $7.7647 (Jun 11, 2014) |
| All-time low | $1.1052 (Jan 22, 2020) |
| Median price | $2.3691 |
| Average price | $3.0118 |
| Largest weekly change | +54.2% (Feb 17, 2021) |
| Weeks tracked | 486 |
| Tracking since | Jun 4, 2014 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LAMIVUDINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 300 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.3821 per EA (NDC 31722075430), effective Nov 13, 2024.
How has the price of LAMIVUDINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE 300 MG TABLET has declined 82.2%. It has been tracked across 486 weekly CMS publications since Jun 4, 2014.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE 300 MG TABLET?
Since Jun 4, 2014, the NADAC for LAMIVUDINE 300 MG TABLET has ranged from a low of $1.1052 (Jan 22, 2020) to a high of $7.7647 (Jun 11, 2014), with a median of $2.3691 per EA.
Are there cheaper alternatives to LAMIVUDINE 300 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LAMIVUDINE 300 MG TABLET, is $1.3014 per EA — about 6% below LAMIVUDINE 300 MG TABLET.
Who manufactures LAMIVUDINE 300 MG TABLET?
LAMIVUDINE 300 MG TABLET (NDC 31722075430) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification